HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

H.C. Wainwright reiterates Buy on argenx stock, $940 target

Created at 3 Jun · 12:19 PM6 sources5 events
IN SHORT

H.C. Wainwright reiterated its Buy rating on argenx stock, setting a price target of $940. The firm's analysis indicates ongoing confidence in the company's future performance.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Key Numbers

$940price target for argenx stock

Who's Involved

H.C. Wainwright
firm reiterating Buy rating on argenx stock
argenx
company with reiterated Buy rating and price target

↳ Why This Matters

Analyst ratings and price targets from firms like H.C. Wainwright can influence investor sentiment and stock price movements for companies like argenx.

Key facts

  • H.C. Wainwright reiterated its Buy rating on argenx stock.
  • H.C. Wainwright set a price target of $940 for argenx stock.

H.C. Wainwright has reiterated its Buy rating on argenx stock, establishing a price target of $940. The firm's continued confidence in argenx's performance and future prospects underpins this decision.

Frequently asked questions

H.C. Wainwright reiterated its Buy rating on argenx stock.

H.C. Wainwright set a price target of $940 for argenx stock.

The firm's analysis suggests continued confidence in argenx's performance and future prospects.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence
CME Headlines
  • New Product Summary: Initial Listing of Fifty-Five (55) Single Stock Futures Contracts — Effective July 27, 2026
    27 Jul · 4:32 PM
  • New Product Summary: Initial Listing of Twenty-Two (22) Micro Single Stock Futures Contracts - Effective July 27, 2026
    27 Jul · 4:11 PM
  • Initial Listing of Additional Event Contract Swaps on Pro Golf Tournaments
    9 Jul · 9:41 AM

How It Developed

3 Jun · 12:01 PM
H.C. Wainwright reiterated its stock rating for Syndax Pharmaceuticals following data presented at ASCO.
Investing.com via PiQSuite
3 Jun · 12:01 PM
H.C. Wainwright maintained its stock price target for Zymeworks at $46.
Investing.com via PiQSuite
3 Jun · 12:01 PM
H.C. Wainwright reiterates its buy rating on Oruka Therapeutics, maintaining a positive outlook.
Investing.com via PiQSuite
3 Jun · 11:45 AM
H.C. Wainwright reiterates PowerBank stock rating after a weak quarter.
Investing.com via PiQSuite
3 Jun · 11:45 AM
H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial data
Investing.com via PiQSuite

Sources

T1
H.C. Wainwright reiterates Syndax Pharmaceuticals stock rating on ASCO datam.piqsuite.com
T1
Zymeworks stock price target maintained at $46 by H.C. Wainwrightm.piqsuite.com
T1
H.C. Wainwright reiterates Oruka Therapeutics stock rating at buym.piqsuite.com
T1
H.C. Wainwright reiterates PowerBank stock rating on weak quarterm.piqsuite.com
T1
H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial datam.piqsuite.com
T1
H.C. Wainwright reiterates Buy on argenx stock, $940 targetm.piqsuite.com

Related Stories

SpaceX Analyst Maintains Neutral Stance Amid Wall Street Buy Frenzy
8 Jul · 10:00 AM
Honeywell Technologies raises 2026 profit targets after reverse stock split
8 Jul · 9:08 PM
SK Hynix $28B ADR bookbuild closes Wednesday amid strong demand
8 Jul · 7:57 AM
JPMorgan Hires Michael Flynn to Lead New Small-Cap Banking Business
8 Jul · 3:03 PM
Goldman Sachs sees buyout opportunities in Japan, South Korea, Australia
9 Jul · 4:19 AM